Preoperative chemotherapy with gemcitabine and S-1, evaluation of safety and efficiency
- Conditions
- gallbladder cancer
- Registration Number
- JPRN-UMIN000005559
- Lead Sponsor
- Division of Hepato-Biliary Pancreatic Surgery , Tohoku University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Not provided
(1) with severe infection (2) with fever >38 degrees C (3) Serious complications (e.g. severe heart desease, plumonary fibrosis, interstitial pneumonia) (4) past history of plumonary fibrosis, interstitial pneumonia or renal failure with dialysis) (5) Simultaneous or metachronous (within 5 years) double cancers, with the exception of intramucosal tumor curable with local therapy (6) with brain metastasis (7) with pericardial fluid (8)Pregnant or lactating women or women of childbearing potential (restrict lactating within 8 weeks after last Panitmumab administration) (9)Patient with severe drug allergy (10)Psychosis or severe mental disorder (11)Inadequate physical condition, as diagnosed by primary physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method